Peer review reports
From: Synergistic anti-proliferative activity of JQ1 and GSK2801 in triple-negative breast cancer
Original Submission | ||
---|---|---|
14 Jan 2022 | Submitted | Original manuscript |
1 Feb 2022 | Reviewed | Reviewer Report |
24 Feb 2022 | Reviewed | Reviewer Report - Ramneet Kaur |
7 Mar 2022 | Reviewed | Reviewer Report |
21 Mar 2022 | Author responded | Author comments - Devin C. Koestler |
22 Mar 2022 | Author responded | Author comments - Devin C. Koestler |
Resubmission - Version 2 | ||
21 Mar 2022 | Submitted | Manuscript version 2 |
23 Mar 2022 | Author responded | Author comments - Devin C. Koestler |
Resubmission - Version 3 | ||
23 Mar 2022 | Submitted | Manuscript version 3 |
7 Apr 2022 | Reviewed | Reviewer Report |
11 Apr 2022 | Reviewed | Reviewer Report |
29 Apr 2022 | Author responded | Author comments - Devin C. Koestler |
Resubmission - Version 4 | ||
29 Apr 2022 | Submitted | Manuscript version 4 |
30 Apr 2022 | Author responded | Author comments - Devin C. Koestler |
Resubmission - Version 5 | ||
30 Apr 2022 | Submitted | Manuscript version 5 |
Publishing | ||
23 May 2022 | Editorially accepted | |
8 Jun 2022 | Article published | 10.1186/s12885-022-09690-2 |